Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amarin: Too Many Positives to Ignore
Seeking Alpha
Thursday, February 24, 2011 - 11:47pm
tags:
Amarin, AMR-101
J&J Recalls 667,632 Sudafed Packages Over Labeling Error
Bloomberg
Thursday, February 24, 2011 - 11:43pm
tags:
recalls, Sudafed, JNJ
AZ's dental unit attracts a slew of suitors
Fierce Pharma
Thursday, February 24, 2011 - 11:40pm
tags:
AstraZeneca, M&A, Astra Tech, dental
Salix Tanks After Drug Setback
Minyanville
Thursday, February 24, 2011 - 11:32pm
tags:
Salix, Xiafaxan, IBS, irritable bowel syndrome
Xenoport Expecting GERD Study Data
Seeking Alpha
Thursday, February 24, 2011 - 11:29pm
tags:
GERD, XenoPort, Horizant
Par Pharma profit rises 64 pct on lower costs
Yahoo/AP
Thursday, February 24, 2011 - 11:19pm
tags:
earnings, Par Pharmaceutical
Centocor’s $1.8B award in Remicade patent case overturned
Bizjournals.com
Thursday, February 24, 2011 - 11:18pm
tags:
Remicade, Abbott Laboratories, patents, Janssen Biotech
Lexicon Pharma's 4Q loss widens as costs rise
Yahoo/AP
Thursday, February 24, 2011 - 11:14pm
tags:
earnings, Lexicon Pharmaceuticals
Human Genome Sciences takes bigger 4Q loss
Yahoo/AP
Thursday, February 24, 2011 - 11:11pm
tags:
earnings, Human Genome Sciences
Is Novartis the Perfect Stock?
Motley Fool
Thursday, February 24, 2011 - 11:04pm
tags:
Novartis
Should You Retire With Merck?
Motley Fool
Thursday, February 24, 2011 - 5:53pm
tags:
Merck
Former Glaxo Lawyer: Name My Co-Conspirators
Pharmalot
Thursday, February 24, 2011 - 5:32pm
tags:
GSK, Wellbutrin SR, off-label, lawsuits
ViroPharma 4Q profit triples on sales
Yahoo/AP
Thursday, February 24, 2011 - 11:41am
tags:
earnings, ViroPharma
Is This the Biggest Threat to Drug Investors?
Motley Fool
Thursday, February 24, 2011 - 11:35am
tags:
investors, Pharmaceutical Market Access and Drug Safety Act, Pfizer, Merck, Eli Lilly
Pozen migraine drug fails to get patent extension
Reuters
Thursday, February 24, 2011 - 8:47am
tags:
Pozen, migraines, patents, GSK, Treximet
Federal judge rules health reform legal
Bizjournals.com
Thursday, February 24, 2011 - 8:35am
tags:
healthcare reform
Pfizer Taps Beer Skills to Enter $14 Billion Insulin Market
Bloomberg
Thursday, February 24, 2011 - 8:32am
tags:
Pfizer, insulin, diabetes
House Committee Targets FDA In Heparin Probe
Pharmalot
Wednesday, February 23, 2011 - 11:47pm
tags:
Heparin, FDA, China
Takeda seeks U.S. approval of hypertension drug
Reuters
Wednesday, February 23, 2011 - 11:40pm
tags:
antihypertensives, Takeda
Pfizer puts remaining Trovan lawsuits to rest
Yahoo/AP
Wednesday, February 23, 2011 - 11:36pm
tags:
Pfizer, lawsuits, Trovan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.